Please login to the form below

Not currently logged in
Email:
Password:

leukaemia

This page shows the latest leukaemia news and features for those working in and with pharma, biotech and healthcare.

FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies

FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies

CAR-T-cell therapy is a type of immunotherapy that involves collecting and using patients’ own immune cells to treat conditions including lymphoma, leukaemia and multiple myeloma.

Latest news

More from news
Approximately 95 fully matching, plus 449 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 16 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM

AMICULUM is an independent family of 11 branded agencies that deliver communications and consultancy services to pharmaceutical, biotechnology and health...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...